PharmX Technologies (ASX:PHX) COGS-to-Revenue : 0.19 (As of Dec. 2023)

View and export this data going back to 1973. Start your Free Trial

What is PharmX Technologies COGS-to-Revenue?

PharmX Technologies's Cost of Goods Sold for the six months ended in Dec. 2023 was A$0.61 Mil. Its Revenue for the six months ended in Dec. 2023 was A$3.14 Mil.

PharmX Technologies's COGS to Revenue for the six months ended in Dec. 2023 was 0.19.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. PharmX Technologies's Gross Margin % for the six months ended in Dec. 2023 was 80.59%.

PharmX Technologies COGS-to-Revenue Historical Data

The historical data trend for PharmX Technologies's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmX Technologies COGS-to-Revenue Chart

PharmX Technologies Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

COGS-to-Revenue

Get a 7-Day Free Trial

0.11

0.13

0.15

0.12

0.20

PharmX Technologies Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
COGS-to-Revenue	Get a 7-Day Free Trial															0.14	0.10	0.13	-	0.19

PharmX Technologies COGS-to-Revenue Calculation

PharmX Technologies's COGS to Revenue for the fiscal year that ended in Jun. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	1.21	/	6.018
	=	0.20

PharmX Technologies's COGS to Revenue for the quarter that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0.61	/	3.142
	=	0.19

PharmX Technologies (ASX:PHX) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

PharmX Technologies's Gross Margin % for the six months ended in Dec. 2023 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	0.61 / 3.142
	=	80.59 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

PharmX Technologies COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of PharmX Technologies's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

PharmX Technologies (ASX:PHX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » PharmX Technologies Ltd (ASX:PHX) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

17 Castlereagh Street, Level 11, Sydney, NSW, AUS, 2000

Website

https://www.corumgroup.com.au

PharmX Technologies Ltd Formerly Corum Group Ltd is an Australia-based software and technology company. The company has a single segment which is Health Services. In Health services, the company develops and distributes business software for the pharmacy industry with particular emphasis on point-of-sale and pharmaceutical dispensing software, support services, and associated computer hardware. It derives a majority of its revenue from the Health services business. the company discontinued the e-commerce business in 2022.